Tag: CBT > DEA Scheduling: Page 4

Cannabis Rescheduling

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

July 29, 2024

Pesticides

Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July

California’s deadly pesticide contamination, federal cannabis rescheduling and CRISPR gene editing were also among the most-read articles this month.

July 25, 2024

Cannabis Rescheduling

43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes

The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.

July 23, 2024

Cannabis Rescheduling

9 US Senators Urge VA to Expand Access to Medical Cannabis for America’s Veterans

Sen. Jeff Merkley led the group in a letter to U.S. Secretary of Veterans Affairs Denis McDonough following the DEA’s rescheduling recommendation.

July 19, 2024

Kentucky

Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’

Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.

July 17, 2024

Cannabis Rescheduling

30,000+ Comments Submitted on DEA’s Proposed Rescheduling Rule

As the public comment period nears an end, comments are continuing to flood in.

July 16, 2024

Federal Cannabis Legalization

25 GOP Lawmakers Condemn Cannabis Rescheduling in New Letter

Sen. James Lankford and Rep. Pete Sessions spearheaded the letter sent to Attorney General Merrick Garland, saying rescheduling lacks “adequate science.”

July 12, 2024

Legislation and Regulation

US House Republicans Nix States’ Rights Cannabis Amendment, Focus on Blocking Rescheduling

The House Appropriations Committee advanced a bill that aims to prevent the DOJ from using funds to reclassify cannabis while allowing it to interfere with state cannabis laws.

July 10, 2024

Cannabis Rescheduling

US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document

The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.

May 23, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Cannabis Rescheduling

White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says

The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.

May 16, 2024

Cannabis Rescheduling

Former Deputy Attorney General James Cole Weighs in on Cannabis Rescheduling and What’s Next

Cole spoke on a media call organized by industry groups and said Congress must ‘act to create a unified regulatory environment that involves both the states and the federal government.’

May 1, 2024